At its meeting on 14 July 2022, the Council discussed the results of the cost analysis of inpatient treatment services in the field: internal diseases. The Council agreed with the valuation proposal presented by the AOTMiT.
The Council took note of the results of the update of the cost analysis serving as the basis for tariff development for inpatient rheumatology services.